# Neuroprotective Effect of the Combined Extract of Mentha piperita and Cornus officinalis Against Neuronal Cell Death and Scopolamine-Induced Memory Impairment

**Authors:** Kang-Il Oh, Junhwan Jeong, Hyesoo Jeong, Yoonjoong Yong, Subin Yeo, Eunkuk Park, Seon-Yong Jeong

PMC · DOI: 10.3390/ijms27052508 · 2026-03-09

## TL;DR

A combination of Mentha piperita and Cornus officinalis extracts protects neurons and improves memory in rats, suggesting potential for treating cognitive decline.

## Contribution

The study demonstrates the neuroprotective and memory-enhancing effects of a combined Mentha piperita and Cornus officinalis extract in both cell and animal models.

## Key findings

- The MC extract reduced H2O2-induced cell injury and increased BDNF mRNA in SK-N-SH cells.
- MC improved cognitive performance in scopolamine-induced memory-impaired rats, as shown by behavioral tests.
- MC restored hippocampal acetylcholine levels and upregulated BDNF and related signaling pathways.

## Abstract

Mild cognitive impairment (MCI) represents an intermediate stage between normal aging and Alzheimer’s disease. This study investigated the neuroprotective effects of a combined extract of Mentha piperita (MP) and Cornus officinalis (CO) (MC) using in vitro and in vivo models. In SK-N-SH cells, pretreatment with MC (50–150 μg/mL) significantly attenuated H2O2-induced cellular injury, as evidenced by a reduction in Annexin V-positive cells and an increase in brain-derived neurotrophic factor (BDNF) mRNA expression. Rosmarinic acid and loganin, the marker compounds of MP and CO, alone or combined at a 6:4 ratio, mitigated H2O2-induced decreases in cell viability and BDNF mRNA. In the in vivo study, male Sprague–Dawley rats were orally administered MC (50, 100, or 200 mg/kg/day) for 28 days, with phosphatidylserine (50 mg/kg/day) serving as a positive control. MC administration significantly improved cognitive performance in rats with scopolamine-induced memory impairment, as demonstrated by increased step-through latency in the passive avoidance test and reduced escape latency in the Morris water maze. Furthermore, in the probe trial, MC-treated rats spent significantly more time in the target quadrant, indicating enhanced spatial memory retention. Mechanistically, MC restored hippocampal acetylcholine levels and reversed the scopolamine-induced decrease in BDNF and its downstream signaling. Specifically, MC upregulated hippocampal BDNF expression and enhanced the phosphorylation of extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and cAMP response element-binding protein (CREB). In conclusion, these results demonstrate that the MC extract possesses potent neuroprotective and learning- and memory-enhancing effects, highlighting its potential as a therapeutic candidate for managing age-related cognitive decline and MCI.

## Linked entities

- **Proteins:** BDNF (brain derived neurotrophic factor), EPHB2 (EPH receptor B2), AKT1 (AKT serine/threonine kinase 1), CREB1 (cAMP responsive element binding protein 1)
- **Chemicals:** H2O2 (PubChem CID 784), acetylcholine (PubChem CID 187), rosmarinic acid (PubChem CID 639655), loganin (PubChem CID 87691)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** age-related cognitive decline (MESH:D003072), MCI (MESH:D060825), Memory Impairment (MESH:D008569), Alzheimer's disease (MESH:D000544)
- **Chemicals:** loganin (MESH:C059516), Scopolamine (MESH:D012601), CO (-), H2O2 (MESH:D006861), MC (MESH:C061001), acetylcholine (MESH:D000109), phosphatidylserine (MESH:D010718), Rosmarinic acid (MESH:C041376)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12985713/full.md

---
Source: https://tomesphere.com/paper/PMC12985713